Asset Sale vs. Stock Sale for a Veterinary Practice: A 2026 Structure Guide

Key takeaways

• Almost every full veterinary practice sale is an asset sale — the buyer buys the assets into a new entity and leaves your old entity and its liabilities behind. A stock sale is usually reserved for partial buy-ins of less than 100 percent.
• Buyers want asset deals for the stepped-up basis. A $2,000,000 goodwill allocation amortizes to roughly $133,333 a year in deductions in an asset sale, and produces zero in a stock sale, so a buyer who accepts stock usually demands a price cut of 30 percent or more.
• Sellers usually lean the other way — a clean stock sale is taxed once at capital gains rates with no depreciation recapture, which is why the structure gets negotiated rather than dictated.
• A C-corporation can get taxed twice on an asset sale. Documenting and selling personal goodwill is the most common way to soften that, but it only works with proper support from a CPA and a veterinary transactions attorney.
• Structure is set at the letter of intent, not at closing. By the time the paperwork is drafted, the asset-versus-stock decision and the price allocation are largely locked, so the time to model the after-tax outcome is before you sign.

Most owners I sit with have spent months thinking about one number. The headline price.

They have a figure in their head, sometimes a multiple they read somewhere, and that is the thing they want to talk about over dinner.

Then I ask a quieter question. Is this an asset deal or a stock deal?

Usually I get a blank look. And that blank look is expensive, because the answer to that one question can move the after-tax money in your pocket by six figures, on the exact same headline price.

This guide is about that question. Not the tax bill in general (we cover the full picture in our guide to the tax consequences of selling a veterinary practice).

This is the structure underneath the tax bill: what actually transfers in an asset sale vs stock sale of a veterinary practice, why buyers and sellers usually want opposite structures, the C-corporation trap that catches owners off guard, and why this all gets decided at the letter of intent, long before any closing documents exist.

One thing up front. This is information, not tax or legal advice.

The structure that fits your practice depends on your entity type and your numbers, and every deal needs a CPA and a veterinary transactions attorney before anything gets signed. What I can do is make sure you walk into that conversation knowing what the words mean and where the money hides.

Asset sale vs stock sale: the plain-English version

Here is the whole distinction in two sentences, the way I would give it to you across the dinner table.

In an asset sale, the buyer buys the things your practice owns (equipment, client records, goodwill, the practice name), usually into a brand-new entity they create, and your old legal entity stays behind with you, along with its history and its liabilities. In a stock sale, the buyer buys your shares in the existing entity, so they step into the same corporation you have been running and inherit everything it owns and everything it owes, taxes and lawsuits and employee obligations included.

That second piece — what happens to the old liabilities — is the part owners underrate. As the veterinary transactions attorneys at Mahan Law describe it, an asset buyer generally leaves the seller’s old legal liabilities behind, while a stock buyer inherits the corporation’s liabilities unless the purchase agreement carves them out through indemnification and reps and warranties.

So already you can feel the tension. The buyer would love to take only the good parts and leave the old entity’s baggage with you.

You would love to hand over the whole entity and walk away clean. That tension is the entire story of this article.

	Asset sale	Stock sale
What the buyer buys	Specific assets (equipment, records, goodwill, name)	Your shares in the existing entity
New or existing entity	Usually a brand-new buyer entity	The existing corporation continues
Old liabilities	Generally stay with the seller	Generally transfer to the buyer
Buyer’s tax basis	Stepped up to purchase price (depreciable / amortizable)	Carries over — no step-up, no write-off
Typical seller tax	Mix of capital gains + ordinary income (recapture, non-compete)	Usually capital gains on the shares
Who tends to prefer it	Buyers	Sellers
Common veterinary use	Almost all 100 percent sales	Partial buy-ins under 100 percent

One important fact sets the baseline for everything below. Across the industry, most veterinary practice sales are structured as asset sales, and a 100 percent sale is almost always an asset sale.

The stock sale tends to show up when a doctor buys into a practice — a partial interest, less than the whole.

Why do buyers almost always want the asset deal?

When a buyer’s team pushes for an asset deal, they are not being difficult. They are doing math, and the math is genuinely compelling on their side.

The reason is something called a stepped-up basis, meaning the buyer gets to record the assets at the price they actually paid, then write that cost off against income over time. Basis is just tax-speak for “what the asset counts as having cost you for tax purposes.” In an asset sale, the buyer’s basis resets to the real purchase price.

In a stock sale, it does not.

That write-off has two engines. Tangible assets like equipment and furniture get depreciated, deducted a piece at a time as they wear out.

And the big one, goodwill (the intangible value of a going practice, its reputation and client base above the value of the equipment), gets amortized over 15 years under IRC Section 197, at about 6.67 percent a year.

Watch what that does to real numbers. Per the Section 197 guidance at Beancount.io, a $2,000,000 goodwill allocation in an asset sale produces about $133,333 a year in deductions for 15 years.

The same $2,000,000 of goodwill in a stock sale produces zero amortization, because the buyer bought shares, not assets, and shares are not a depreciable asset.

So put yourself in the buyer’s seat. The asset deal hands them roughly $2,000,000 of deductions over time.

The stock deal hands them nothing of the kind. That gap is why, in deal after deal, a buyer who agrees to a stock sale typically demands a purchase-price reduction of around 30 percent or more to offset the lost write-off, and why almost all veterinary practices end up sold as asset deals.

There is a second buyer motive stacked on top of the tax one. The clean-liability point from earlier.

An asset buyer generally leaves your old entity’s legal exposure behind, so they are not inheriting a malpractice claim or an old tax issue they did not create. Between the stepped-up basis and the liability shield, the asset structure is simply the safer, cheaper deal for a buyer, which is why it dominates the market.

Why do sellers in an asset sale vs stock sale often lean the other way?

Now flip the table. If the asset deal is so good for the buyer, what does it cost you?

A few things, and they are worth understanding before you concede the structure. In an asset sale the price gets split across asset classes that are taxed at very different rates, and not all of it gets the friendly treatment.

Here is the spread that makes this matter. For 2026, per the Tax Foundation, ordinary income tax rates reach up to 37 percent federal, while long-term capital gains are taxed at 0, 15, or 20 percent depending on your income.

That difference between roughly 37 percent and 20 percent is the single reason structure and allocation move so much money.

In an asset sale, your tangible assets and any non-compete covenant you sign are taxed at ordinary income rates above basis, while your intangibles (goodwill, client and patient records) get the lower long-term capital gains rate. So you want as much of the price as possible called goodwill, and the buyer wants more of it called depreciable equipment so they can write it off faster.

That pull in opposite directions is the allocation fight, and we will get into it in a moment.

Then there is the part that genuinely surprises sellers. Depreciation recapture, under Section 1245, is the rule that taxes the portion of your gain attributable to depreciation you already claimed at ordinary income rates, up to 37 percent, instead of capital gains rates. You took those equipment deductions over the years.

When you sell the assets, the IRS effectively wants some of that benefit back at the higher rate.

Across the deals we see, on a practice with roughly $300,000 of accumulated depreciation, recapture can add somewhere in the range of $60,000 to $110,000 in tax that many sellers never anticipated. A clean stock sale sidesteps recapture on your side entirely, because you are selling shares, not the depreciated equipment underneath them.

Add it up and a stock sale, when it is available and clean, often means the whole gain is taxed once at capital gains rates, the old entity and its liabilities go to the buyer, and there is no recapture bill. That is why a seller’s instinct frequently runs toward stock even though the market mostly delivers asset deals.

The structure you actually get is the negotiated middle, and the difference between handling that negotiation well and handling it badly is real money. In our experience, the gap between a well-structured and a poorly structured deal can be six figures.

The allocation fight: Form 8594 and the seven buckets

Once you have an asset deal, the price does not just sit there as one number. It gets divided, on paper, into categories.

And both sides have to agree on the division and report the same numbers to the IRS.

This is purchase price allocation, and it runs on IRS Form 8594 — the Asset Acquisition Statement under Section 1060. Per the IRS, both buyer and seller file Form 8594 and allocate the price using the residual method across seven asset classes, with goodwill and going-concern value sitting in Class VII, absorbing whatever is left after Classes I through VI are filled in at fair market value.

In plain terms, you assign fair value to the cash, the receivables, the inventory, the equipment, and so on, and whatever price is left over after all of that lands in the goodwill bucket. The fight is over how big each bucket gets, because each bucket is taxed differently.

You, the seller, want a big goodwill bucket, because goodwill is capital gains. The buyer wants a bigger equipment-and-tangibles bucket, because those depreciate faster than goodwill’s 15-year amortization, giving them quicker write-offs.

The non-compete is its own flashpoint — it is ordinary income to you but useful to the buyer, so where that value lands gets negotiated too.

Because the allocation must reflect genuine fair market value and both parties report it, you cannot simply invent the split you want. This is exactly the kind of thing a CPA and a veterinary transactions attorney model together before the letter of intent gets signed, not after.

Get it modeled early and you negotiate from knowledge. Get it modeled late and you are reacting to a structure someone else already shaped.

The C-corporation trap

There is one entity type that turns this whole conversation from “interesting” to “urgent,” and that is the C-corporation.

If your practice is a C-corp, an asset sale can be taxed twice. Per dvm360, the gain is taxed once inside the corporation when it sells the assets, and then again when the after-tax proceeds are distributed out to you as the shareholder.

For goodwill, that can mean a layer of tax inside the corporation plus ordinary income on the distribution to you. Two bites out of the same apple.

This is the double-taxation problem, and it is why a C-corp owner cannot treat structure as an afterthought. The exact mechanics of that second layer depend on how the entity is liquidated and distributed, which is genuinely a question for your tax advisor, not a blog.

But the headline is simple. The same asset sale that is clean for an S-corp or an LLC owner can be punishing for a C-corp owner who walks in unprepared.

There is a well-established way to soften it, and it leans on something specific to medicine. Personal goodwill is the slice of your practice’s value tied to you personally, your reputation and skill and the client relationships you built, rather than to the entity. In veterinary practices the lead doctor often drives client loyalty directly, which makes personal goodwill especially relevant.

Across the industry, when personal goodwill is documented and sold directly by the individual veterinarian rather than by the corporation, that portion can be taxed once, at the shareholder level, as capital gain. That sidesteps the corporation-level layer on the part of the deal it covers.

It is not automatic. It requires a documented, defensible case that the goodwill genuinely belongs to you as a person, the kind of fact-specific analysis that an attorney and CPA build deliberately, not something you assert on the closing day.

If you are a C-corp owner, this single paragraph may be the most valuable one in the article. Model the double-tax exposure and the personal-goodwill case early, because the planning has to be in place before the deal is structured, not bolted on afterward.

Section 338(h)(10): the deal that is stock legally but asset for tax

Sometimes both sides want different things and there is a structure that bridges them. The most common one in practice sales is a Section 338(h)(10) election.

Here is what it does. Per RKL LLP, a 338(h)(10) election lets a qualified stock purchase of an S-corporation — or a C-corp that is owned by another corporation — be treated as an asset purchase for tax purposes, while the deal still closes legally as a stock sale.

The buyer takes the shares, so legally it is a stock deal, but for taxes the buyer gets the stepped-up basis of an asset deal. Best of both worlds, from the buyer’s side.

It has hard limits. As RKL notes, the election is unavailable when a C-corporation’s stock is owned by individuals, which rules out a large share of solo and small-group practices organized as C-corps.

Eligibility runs on specific statutory tests, which is firmly CPA-and-attorney territory.

And it is not free to the seller. Because a 338(h)(10) election can leave a seller worse off on taxes than a plain stock sale would, sellers frequently demand a higher purchase price as compensation for taking on that added tax burden.

That is the normal, rational trade. The buyer gets the tax structure they want, and they pay up for it.

Which, again, is why none of this should be a surprise at closing — it is a price-and-structure negotiation that belongs at the letter of intent.

One more layer: the 3.8% surtax higher-income sellers forget

Before we leave the tax math, one quiet add-on that catches successful owners.

On top of the capital gains rate, higher-income sellers can owe a Net Investment Income Tax (NIIT) of 3.8 percent. Per Kiplinger, it applies for sellers with income over $200,000 single or $250,000 married filing jointly, on the investment-income portion above the threshold.

On a meaningful practice sale, that 3.8 percent rides on top of the capital-gain portion and nudges your effective rate up.

It is not a reason to choose one structure over another by itself. It is a reason the after-tax modeling has to be done with real numbers and real thresholds, not a rule of thumb.

The headline price and the check you actually keep are two different figures, and the distance between them is exactly what your CPA is for. We walk through the broader version of that gap in our breakdown of the tax consequences of a veterinary practice sale.

Where the PE-backed buyers fit

A lot of the structure questions I get come from owners weighing an offer from a private equity firm or a PE-backed group, so it is worth saying where they land on all this.

Institutional buyers are sophisticated. Their deal teams know exactly why the asset structure and the stepped-up basis matter to them, and they model the allocation carefully.

They also bring tools like the 338(h)(10) election to the table when your entity type allows it, precisely so they can capture the asset-deal tax benefit on a transaction that is legally a stock purchase.

That sophistication is not a threat. It just means the owner on the other side needs to be equally well advised, because a buyer who has done a hundred of these and a seller doing their first one are not negotiating from the same position.

We get into how those buyers price practices in our look at how much private equity is paying for veterinary practices, and the broader landscape of buyers in our veterinary practice consolidators directory.

Mars Veterinary Health is the one strategic, family-owned exception in a field that is otherwise largely PE-backed, and it runs its own playbook. But on structure, the same fundamentals apply to nearly every institutional buyer.

They want the asset treatment, and they will structure to get it where the law allows.

The deal-structure conversation also connects to how the rest of the price is paid — cash at close, earnout, rollover equity. An earnout is part of the price paid later only if the practice hits agreed targets, and rollover equity means keeping a slice of ownership in the new entity instead of taking all cash.

Those moving parts have become common in 2025 and 2026 deals, and they interact with the asset-versus-stock decision in ways that, again, need to be modeled together rather than one at a time.

How structure actually gets decided: at the LOI

Here is the part owners most often get backwards. They assume structure is a closing-document detail, something the lawyers sort out near the end.

It is not.

The asset-versus-stock decision, and the broad shape of the allocation, are set at the letter of intent, the short document that lays out the deal’s key terms before the deep due-diligence phase begins. By the time the full purchase agreement is being drafted, the structure is largely locked, because it was agreed in principle at the LOI.

We go deep on that document in our guide to the veterinary practice letter of intent.

This is why the modeling has to happen before you sign the LOI, not after. If you wait until the closing documents to ask your CPA “wait, what does this structure cost me?”, you are asking after the leverage to change it has mostly evaporated.

The owner who has modeled the after-tax outcome of both structures before the LOI negotiates from a position of knowledge. The owner who has not is negotiating blind on the single decision that most affects what they keep.

And this connects directly to leverage, which is the other half of the picture. The methodology we use to sell practices is the Elite Selling System.

We hand-select and vet every buyer who gets to bid on your practice, the way a doorman with a velvet rope lets in only the right people, then run a private competitive window inside that vetted group. When several qualified buyers are competing, structure becomes something you can negotiate rather than something a single buyer dictates.

A lone buyer with no competition sets the terms, including the structure. Competing buyers have to meet your terms to win, and that is when a seller-friendly allocation or a price premium for a 338(h)(10) election becomes achievable instead of theoretical.

Is a veterinary practice an asset sale vs stock sale by default?

So where does a typical owner actually land? Let me set honest expectations.

If you are selling 100 percent of your practice, expect an asset deal. That is the market, and fighting it outright usually just costs you buyers.

The asset-versus-stock decision is negotiated rather than dictated, but the strong default for a full sale is the asset structure, and your energy is better spent on the allocation and the after-tax math than on insisting on a stock deal a buyer will not accept without a steep discount.

If a doctor is buying into your practice — a partial interest — a stock sale becomes much more natural, and the math looks different. And if you are a C-corp owner, the structure question stops being academic and becomes the thing you plan around first, with personal goodwill usually the lever that matters most.

What I want you to take from all of this is not a rule about which structure to pick. It is a sense of where the money is hiding, so that when your CPA and your attorney model your specific situation, you understand what they are weighing and why it matters.

Two practices with identical headline prices can deliver very different checks depending on structure, entity type, and allocation. That difference is yours to protect, but only if you engage it early.

What to do next

If you are anywhere inside the window before a sale, the move is the same. Get your structure modeled before you are staring at a letter of intent, not after.

Sit down with a CPA who understands practice sales and a veterinary transactions attorney, and have them run the after-tax outcome of both an asset deal and, where it is even available, a stock or 338(h)(10) structure. If you are a C-corp, make the personal-goodwill analysis part of that first conversation, because it has to be built deliberately and early.

The goal is simple: walk into the LOI negotiation knowing exactly what each structure does to the check you keep.

And keep more than one qualified buyer in the room. Structure is far easier to negotiate when a buyer knows another bidder is right behind them.

Get a Free Practice Value Estimate →

We pull your numbers, build a defensible normalized EBITDA, and help you understand the after-tax shape of a deal — asset versus stock, allocation, and where your specific entity type changes the math — before any buyer ever sees your practice. Then we identify the right group of qualified buyers for your profile and run a competitive process that keeps the structure negotiable instead of dictated.

The estimate is free and there is no obligation to engage further. The Transitions Elite engagement model is success-based, with no upfront fees and no retainer, so we are paid only when a deal closes and only out of the value our process protects and delivers.

---

Further reading

These are the related TE resources I would point any vet toward as they think through structure and getting sale-ready. Each goes deep on one piece of the decision.

• Tax consequences of selling a veterinary practice — the full after-tax picture, of which asset-versus-stock is one major lever.
• The veterinary practice letter of intent — the document where structure actually gets set, and what to watch for before you sign.
• How to value a veterinary practice — what the practice is worth before structure ever enters the conversation.
• How much private equity is paying for veterinary practices — the four components of a PE-backed offer and why the headline rarely equals the check.
• EBITDA benchmarks in vet practice sales — what practices actually sell for in 2026, by size and by sale process.
• Sell my veterinary practice — the owner’s decision guide to the sale paths available in 2026.
• Guide to selling a veterinary practice — the full process from advisor engagement through closing.

Frequently asked questions

What is the difference between an asset sale and a stock sale for a veterinary practice?

In an asset sale, the buyer purchases specific assets of your practice — equipment, client records, goodwill, the practice name — usually into a new entity, and your old legal entity and its liabilities stay with you. In a stock sale, the buyer purchases your shares in the existing entity and inherits the whole corporation, including its tax history and liabilities.

Most full veterinary practice sales are structured as asset sales. Stock sales are typically reserved for partial buy-ins of less than 100 percent.

Why do buyers prefer an asset sale when buying a veterinary practice?

Buyers prefer asset sales because they get a stepped-up tax basis and leave old liabilities behind. In an asset sale the buyer records the assets at the price paid and writes them off over time — goodwill is amortized over 15 years under IRC Section 197 at about 6.67 percent a year, and tangible assets are depreciated.

A $2,000,000 goodwill allocation produces roughly $133,333 a year in deductions. In a stock sale that same goodwill produces zero amortization, which is why a buyer who accepts a stock deal usually demands a price reduction of 30 percent or more.

Why would a seller prefer a stock sale?

Sellers often prefer a stock sale because the entire gain on the shares is typically taxed once at the long-term capital gains rate, the old entity and its liabilities transfer to the buyer, and there is no depreciation recapture taxed at ordinary income rates on the seller’s side. The catch is that the buyer loses the stepped-up basis, so the buyer usually pays less for a stock deal or demands a higher allocation to items that hurt the seller.

The structure is almost always negotiated, and the difference between a well-structured and a poorly structured deal can run into six figures.

How does purchase price allocation work in a veterinary practice asset sale?

In an asset sale the price is split across asset classes that are taxed differently, and both buyer and seller report the allocation on IRS Form 8594 using the residual method across seven asset classes. Tangible assets like equipment and inventory and any non-compete covenant are taxed at ordinary income rates above basis, while intangibles like goodwill and client records are taxed at the lower long-term capital gains rate.

Sellers favor allocating more to goodwill; buyers favor allocating more to depreciable tangibles. Because both sides must agree and report the same numbers, allocation is negotiated.

What is the C-corp double-tax problem in a veterinary practice sale?

If your practice is a C-corporation, an asset sale can be taxed twice: once inside the corporation when it sells the assets, and again when the after-tax proceeds are distributed to you as the shareholder. For goodwill, that can mean tax inside the corporation plus ordinary income on the distribution.

Owners can often mitigate this by documenting and selling personal goodwill directly from the individual, so that portion is taxed once at the shareholder level. This is fact-specific and requires a CPA and a veterinary transactions attorney.

What is a Section 338(h)(10) election?

A Section 338(h)(10) election lets a qualified stock purchase of an S-corporation (or a C-corp owned by another corporation) be treated as an asset purchase for tax purposes. The deal closes legally as a stock sale, so the buyer takes the shares, but for taxes the buyer gets the stepped-up basis of an asset deal.

It is unavailable when a C-corp’s stock is owned by individuals. Because the election can leave the seller worse off on taxes than a clean stock sale, sellers frequently demand a higher price in exchange for making it.

What is depreciation recapture and how does it affect a practice sale?

Depreciation recapture, under Section 1245, taxes the part of an asset-sale gain that comes from depreciation or amortization you already claimed, at ordinary income rates up to 37 percent, rather than at capital gains rates. For a practice with roughly $300,000 of accumulated depreciation, sell-side estimates put the added tax at about $60,000 to $110,000 — a bill many sellers do not see coming.

It is one more reason the asset-versus-stock decision and the allocation should be modeled by a tax professional before you sign anything.

Is a veterinary practice usually sold as an asset sale or a stock sale?

Most full veterinary practice sales are asset sales. A 100 percent sale is almost always structured as an asset sale because the buyer wants the stepped-up basis and wants to leave old liabilities behind.

Stock sales are typically reserved for partial buy-ins of less than 100 percent, or for deals where a Section 338(h)(10) election lets a stock purchase be taxed like an asset purchase. The right structure for any specific practice depends on entity type and the numbers, and should be modeled with a CPA and a veterinary transactions attorney.

---

Sources

Tax structure, allocation, and IRS guidance

1. IRS. “About Form 8594, Asset Acquisition Statement Under Section 1060.” irs.gov
2. Tax Foundation. “2026 Tax Brackets and Federal Income Tax Rates.” taxfoundation.org
3. Beancount.io. “Section 197 Amortization of Intangibles in an Asset Acquisition — Goodwill, Customer Lists, Non-Competes.” 2026. beancount.io
4. RKL LLP. “Section 338(h)(10) Transaction Structure: Pros and Cons for Sellers and Buyers.” rklcpa.com
5. Kiplinger. “Capital Gains Tax Rates.” kiplinger.com

Veterinary practice sale structure and deal mechanics

6. Mahan Law (Law Office of Anthony A. Mahan). “Asset Purchase v. Share Purchase.” mahanlaw.com
7. dvm360. “How is a practice’s good will valued and taxed?” dvm360.com